Ticker LaunchUnderwriter
Leerink Partners
Leerink Partners appears as underwriter on 77 US IPOs and 4 SPAC IPOs tracked by Ticker Launch since 2019, leading 13 of them as lead-left (first named) bank.
US IPOs77
SPAC IPOs4
Deals by year: 2026: 11 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 22 · 2020: 16 · 2019: 14 · 2018: 1
Deals
| Company | Type | Date | Size | Role |
|---|---|---|---|---|
| Retension Pharmaceuticals, Inc. | IPO | Oct 9, 2026 | $45M | Lead-left |
| Latigo Biotherapeutics, Inc. | IPO | Aug 7, 2026 | $345.6M | Syndicate |
| Kardigan, Inc. | IPO | Jun 18, 2026 | $400M | Syndicate |
| Parabilis Medicines, Inc. | IPO | Jun 10, 2026 | $670M | Lead-left |
| Eloxx Pharmaceuticals, Inc. | IPO | Jun 9, 2026 | — | Lead-left |
| Seaport Therapeutics, Inc. | IPO | May 1, 2026 | $254.9M | Syndicate |
| Kailera Therapeutics, Inc. | IPO | Apr 17, 2026 | $625M | Syndicate |
| AgomAb Therapeutics NV | IPO | Feb 6, 2026 | $200M | Syndicate |
| SpyGlass Pharma, Inc. | IPO | Feb 6, 2026 | $150M | Syndicate |
| Veradermics, Inc | IPO | Feb 4, 2026 | $256.3M | Syndicate |
| Aktis Oncology, Inc. | IPO | Jan 9, 2026 | $317.7M | Syndicate |
| Lumexa Imaging Holdings, Inc. | IPO | Dec 12, 2025 | $462.5M | Syndicate |
| Evommune, Inc. | IPO | Nov 6, 2025 | $150M | Syndicate |
| LB Pharmaceuticals Inc | IPO | Sep 12, 2025 | $285M | Lead-left |
| Beta Bionics, Inc. | IPO | Jan 31, 2025 | $204M | Syndicate |
| Maze Therapeutics, Inc. | IPO | Jan 31, 2025 | $140M | Syndicate |
| Ardent Health, Inc. | IPO | Jul 18, 2024 | $192M | Syndicate |
| Alumis Inc. | IPO | Jun 28, 2024 | — | Syndicate |
| Boundless Bio, Inc. | IPO | Mar 28, 2024 | $100M | Syndicate |
| Kyverna Therapeutics, Inc. | IPO | Feb 8, 2024 | $319M | Syndicate |
| BrightSpring Health Services, Inc. | IPO | Jan 26, 2024 | $693.3M | Syndicate |
| Lexeo Therapeutics, Inc. | IPO | Nov 6, 2023 | $100M | Syndicate |
| Abivax S.A. | IPO | Oct 23, 2023 | $235.8M | Syndicate |
| Turnstone Biologics Corp. | IPO | Jul 24, 2023 | $80M | Syndicate |
| AN2 Therapeutics, Inc. | IPO | Mar 28, 2022 | $69M | Syndicate |
| Valuence Merger Corp. I | SPAC IPO | Mar 2, 2022 | $200M | Lead-left |
| Arcellx, Inc. | IPO | Feb 7, 2022 | $123.8M | Syndicate |
| Amylyx Pharmaceuticals, Inc. | IPO | Jan 10, 2022 | $190M | Syndicate |
| Airsculpt Technologies, Inc. | IPO | Oct 29, 2021 | $77M | Syndicate |
| Minerva Surgical Inc | IPO | Oct 25, 2021 | $75M | Syndicate |
| Theseus Pharmaceuticals, Inc. | IPO | Oct 7, 2021 | $160M | Syndicate |
| DICE Therapeutics, Inc. | IPO | Sep 16, 2021 | $204M | Syndicate |
| PROCEPT BioRobotics Corp | IPO | Sep 16, 2021 | $163.9M | Syndicate |
| RxSight, Inc. | IPO | Jul 30, 2021 | $117.6M | Syndicate |
| Caribou Biosciences, Inc. | IPO | Jul 23, 2021 | $304M | Syndicate |
| Elevation Oncology, Inc. | IPO | Jun 25, 2021 | — | Syndicate |
| Century Therapeutics, Inc. | IPO | Jun 21, 2021 | — | Syndicate |
| Molecular Partners AG | IPO | Jun 16, 2021 | $63.8M | Syndicate |
| Werewolf Therapeutics, Inc. | IPO | Apr 30, 2021 | $120M | Syndicate |
| NeuroPace Inc | IPO | Apr 23, 2021 | $102M | Syndicate |
| Recursion Pharmaceuticals, Inc. | IPO | Apr 16, 2021 | $436.4M | Syndicate |
| VectivBio Holding AG | IPO | Apr 9, 2021 | $127.5M | Syndicate |
| Design Therapeutics, Inc. | IPO | Mar 26, 2021 | $240M | Syndicate |
| LAVA Therapeutics NV | IPO | Mar 26, 2021 | $100.5M | Syndicate |
| Olink Holding AB (publ) | IPO | Mar 26, 2021 | — | Syndicate |
| Connect Biopharma Holdings Ltd | IPO | Mar 19, 2021 | $191.2M | Syndicate |
| Prometheus Biosciences, Inc. | IPO | Mar 12, 2021 | $190M | Lead-left |
| Decibel Therapeutics, Inc. | IPO | Feb 12, 2021 | $127.1M | Syndicate |
| Pharvaris N.V. | IPO | Feb 8, 2021 | $165.4M | Syndicate |
| Cullinan Therapeutics, Inc. | IPO | Jan 11, 2021 | $249.9M | Syndicate |
| AbCellera Biologics Inc. | IPO | Dec 14, 2020 | $483M | Syndicate |
| Health Connect Acquisitions Corp. I | SPAC IPO | Dec 14, 2020 | $360M | Lead-left |
| ARS Pharmaceuticals, Inc. | IPO | Dec 4, 2020 | $241.5M | Syndicate |
| Kinnate Biopharma Inc. | IPO | Dec 3, 2020 | — | Syndicate |
| Avista Healthcare Public Acquisition Corp. | SPAC IPO | Nov 16, 2020 | $56.9M | Syndicate |
| Damora Therapeutics, Inc. | IPO | Oct 30, 2020 | $85M | Syndicate |
| Opthea Ltd | IPO | Oct 19, 2020 | — | Syndicate |
| CalciMedica, Inc. | IPO | Sep 25, 2020 | $90M | Lead-left |
| Outset Medical, Inc. | IPO | Sep 16, 2020 | $241.7M | Syndicate |
| Pandion Therapeutics, Inc. | IPO | Jul 17, 2020 | $135M | Syndicate |
| Accolade, Inc. | IPO | Jul 2, 2020 | — | Syndicate |
| Forma Therapeutics Holdings, Inc. | IPO | Jun 22, 2020 | $277.6M | Syndicate |
| Applied Molecular Transport Inc. | IPO | Jun 5, 2020 | $154M | Syndicate |
| Keros Therapeutics, Inc. | IPO | Apr 8, 2020 | $96M | Syndicate |
| Zentalis Pharmaceuticals, Inc. | IPO | Apr 6, 2020 | $165.2M | Syndicate |
| Revolution Medicines, Inc. | IPO | Feb 13, 2020 | $238M | Syndicate |
| 89bio, Inc. | IPO | Nov 12, 2019 | $84.9M | Syndicate |
| Progyny, Inc. | IPO | Oct 25, 2019 | $130M | Syndicate |
| Innate Pharma SA | IPO | Oct 18, 2019 | — | Syndicate |
| BioNTech SE | IPO | Oct 11, 2019 | $150M | Syndicate |
| Satsuma Pharmaceuticals, Inc. | IPO | Sep 13, 2019 | $82.5M | Syndicate |
| Castle Biosciences Inc | IPO | Jul 26, 2019 | $64M | Lead-left |
| BridgeBio Pharma, Inc. | IPO | Jun 28, 2019 | $348.5M | Syndicate |
| Trevi Therapeutics, Inc. | IPO | May 8, 2019 | $55M | Lead-left |
| HOOKIPA Pharma Inc. | IPO | Apr 19, 2019 | $84M | Lead-left |
| Turning Point Therapeutics, Inc. | IPO | Apr 18, 2019 | $166.5M | Syndicate |
| Genfit S.A. | IPO | Mar 27, 2019 | $135.1M | Lead-left |
| TCR2 Therapeutics Inc. | IPO | Feb 15, 2019 | $75M | Syndicate |
| Avedro Inc | IPO | Feb 14, 2019 | $70M | Syndicate |
| Gossamer Bio, Inc. | IPO | Feb 8, 2019 | $276M | Lead-left |
| DFB Healthcare Acquisitions Corp. | SPAC IPO | Feb 15, 2018 | $250M | Syndicate |
See where Leerink Partners ranks: US IPOs · SPAC IPOs
Track Leerink Partners's next deals
Subscribers get each new filing and pricing the morning after, with alerts and Excel export.